These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38433526)

  • 1. ILT4 facilitates angiogenesis in non-small cell lung cancer.
    Wang S; Wang J; Gong W; Zhang F; Chen X; Xu H; Han Y; Fu X; Wang L; Li J; Gao A; Sun Y
    Cancer Sci; 2024 May; 115(5):1459-1475. PubMed ID: 38433526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.
    Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y
    Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 4. ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.
    Li J; Gao A; Zhang F; Wang S; Wang J; Wang J; Han S; Yang Z; Chen X; Fang Y; Jiang G; Sun Y
    Cancer Lett; 2021 Mar; 501():263-276. PubMed ID: 33152402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer.
    Wang L; Geng T; Guo X; Liu J; Zhang P; Yang D; Li J; Yu S; Sun Y
    Mol Med Rep; 2015 Apr; 11(4):2789-96. PubMed ID: 25482926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived Immunoglobulin-like transcript 4 facilitates angiogenesis of colorectal cancer.
    Liu J; Zhang F; He J; Wang S; Wang L; Li J; Shi W; Han Y; Gao A; Sun Y
    Am J Cancer Res; 2023; 13(2):419-435. PubMed ID: 36895964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.
    Zhang Y; Zhao J; Qiu L; Zhang P; Li J; Yang D; Wei X; Han Y; Nie S; Sun Y
    Tumour Biol; 2016 Aug; 37(8):11187-98. PubMed ID: 26939901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma.
    García M; Palma MB; Verine J; Miriuka S; Inda AM; Errecalde AL; Desgrandchamps F; Carosella ED; Tronik-Le Roux D
    BMC Cancer; 2020 Jul; 20(1):624. PubMed ID: 32620162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.
    Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y
    FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting angiogenesis in squamous non-small cell lung cancer.
    Piperdi B; Merla A; Perez-Soler R
    Drugs; 2014 Mar; 74(4):403-13. PubMed ID: 24578213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.
    Yao M; Zhang W; Zhang Q; Xing L; Xu A; Liu Q; Cui B
    Lung; 2011 Dec; 189(6):453-60. PubMed ID: 21959954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PVT1 Promotes Angiogenesis by Regulating miR-29c/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway in Non-Small-Cell Lung Cancer (NSCLC).
    Mao Z; Xu B; He L; Zhang G
    Med Sci Monit; 2019 Jul; 25():5418-5425. PubMed ID: 31326971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.
    Gao A; Liu X; Lin W; Wang J; Wang S; Si F; Huang L; Zhao Y; Sun Y; Peng G
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.
    Rapp J; Kiss E; Meggyes M; Szabo-Meleg E; Feller D; Smuk G; Laszlo T; Sarosi V; Molnar TF; Kvell K; Pongracz JE
    BMC Cancer; 2016 Nov; 16(1):915. PubMed ID: 27876017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer.
    Zhang X; Wang Y; Fan J; Chen W; Luan J; Mei X; Wang S; Li Y; Ye L; Li S; Tian W; Yin K; Ju D
    J Immunother Cancer; 2019 Dec; 7(1):346. PubMed ID: 31829270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
    Yu W; Chen L; Yang YQ; Falck JR; Guo AM; Li Y; Yang J
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):619-29. PubMed ID: 21120482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer.
    Deacon K; Onion D; Kumari R; Watson SA; Knox AJ
    J Biol Chem; 2012 Nov; 287(47):39967-81. PubMed ID: 22992725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.
    Chatterjee S; Heukamp LC; Siobal M; Schöttle J; Wieczorek C; Peifer M; Frasca D; Koker M; König K; Meder L; Rauh D; Buettner R; Wolf J; Brekken RA; Neumaier B; Christofori G; Thomas RK; Ullrich RT
    J Clin Invest; 2013 Apr; 123(4):1732-40. PubMed ID: 23454747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
    Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
    PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.